Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pedro de Mingo Casado"'
Autor:
Inmaculada Pérez-Sánchez, Juan Ramón Gimeno-Blanes, Guillermo Glover, Maria Elisa Nicolas Rocamora, María Sabater-Molina, Fuensanta Escudero, Pedro de Mingo Casado
Publikováno v:
Current Gene Therapy. 18:246-251
Duchenne muscular dystrophy is a disorder with variable expression caused by framedisrupting mutations in the dystrophin gene. It is characterized by progressive muscle weakness and dilated cardiomyopathy. In-frame dystrophin mutations cause a clinic
Autor:
Elena, Martínez-Cayuelas, Eduardo, Martínez-Salcedo, Helena, Alarcón-Martínez, Alberto, Puche-Mira, Rosario, Domingo-Jiménez, Pedro, de Mingo-Casado, Cristina, Serrano-García
Publikováno v:
Revista de neurologia. 60(7)
Hirayama disease is a rare children's muscular atrophy that affects young Asian males, with muscular atrophy usually in one of the upper limbs that progresses slowly and later stabilises. It is diagnosed by means of electromyographic/electroneurograp
Autor:
María Luisa Martínez-Navarro, Manuel Amorin-Díaz, Andres Fernández Barreiro, José Meca-Lallana, Pedro de Mingo-Casado
Publikováno v:
Clinical therapeutics. 32(6)
Background: Treatment with interferon-β (IFN-β) has been related to worsening of muscle spasticity in patients with multiple sclerosis (MS). However, there are no specific data on the effects of glatiramer acetate (GA) on spasticity. Objective: The